Market Overview:
The global medical bionic implants market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, technological advancements in medical implants, and rising demand for minimally invasive surgeries. The artificial heart segment is expected to account for the largest share of the global medical bionic implants market in 2018. This segment is expected to grow at a CAGR of 8% during the forecast period. The large share of this segment can be attributed to increasing prevalence of heart diseases and technological advancements in cardiac devices. The hospitals segment is expected to account for the largest share of the global medical bionic implants market in 2018.
Product Definition:
A medical bionic implant is a device that is implanted into the body to replace or augment a missing or damaged body part. These devices are often made of metal, plastic, and/or ceramic materials. They can be used to replace missing limbs, organs, or other body parts. Medical bionic implants can also be used to improve the function of impaired organs or muscles.
Artificial Heart:
Artificial heart, also known as bionic heart or bio-artificial heart is a device that provides life-supporting functions for patients suffering from chronic cardiac insufficiency. It is used to treat conditions such as cardiogenic shock, acute myocardial infarction (AMI), and congestive failure of the left ventricle (LVF).
Artificial Kidney:
Artificial kidney is a machine that functions as a substitute for the human kidney. It is used in cases where people have lost their lives or their kidneys due to diseases such as renal failure, acute dialysis, and chronic renal dysfunction.
Application Insights:
Based on application, the global medical bionic implants market is segmented into hospitals, clinics and other healthcare facilities, research institutes and others. The hospitals segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of chronic diseases that require frequent surgeries for treatment coupled with increasing government funding for the development of advanced healthcare technologies.
The clinics and other health-care facilities segment is expected to grow at a lucrative rate over the forecast period owing to an increase in demand for minimally invasive procedures that lead to reduced hospital stays along with cost savings incurred by reducing medication errors due to automation. Furthermore, growing awareness regarding implantable devices used as substitutes for vital organs such as heart, lungs & liver coupled with rising disposable income will boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing government funding for bionic implant research, growing patient awareness levels coupled with high healthcare expenditure levels in this region as compared to others. In addition, a rise in chronic diseases that require long-term medical care and treatment are also responsible for maintaining the dominance of North America over other regions during the forecast period.
Asia Pacific is anticipated to grow at a lucrative rate over the coming years due to factors such as improving healthcare infrastructure and rising patient disposable income levels which result into higher health insurance coverage rates thereby driving demand for advanced medical devices such as bionics implants among patients seeking treatment options across this region.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global medical bionic implants market is expected to grow at a CAGR of over 7% during the forecast period. This can be attributed to the increasing demand for minimally invasive surgeries, which offer several benefits such as shorter hospital stays, reduced pain and blood loss, and faster recovery times.
- Growing geriatric population: The global geriatric population is expected to grow at a CAGR of over 5% during the forecast period. This will lead to an increase in the number of patients requiring treatment for age-related conditions such as arthritis, Alzheimer’s disease, and Parkinson’s disease, thereby driving the growth of the medical bionic implants market.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes mellitus, and heart disease is increasing globally due to changing lifestyles and rising levels of pollution. This is leading more people to seek treatment for these conditions using medical bionic implants devices which are designed specifically for their treatment needs thereby propelling market growth .
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Bionic Implants Market Research Report
By Type
Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs, Others
By Application
Hospitals, Clinics, Research Institutes, Others
By Companies
Medtronic, Boston Scientific, Roche, Zimmer Biomet, Asahi Kasei Medical, Baxter International, Abiomed, Berlin Heart, Thoratec, Gambro AB, Jarvik Heart
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Medical Bionic Implants Market Report Segments:
The global Medical Bionic Implants market is segmented on the basis of:
Types
Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Roche
- Zimmer Biomet
- Asahi Kasei Medical
- Baxter International
- Abiomed
- Berlin Heart
- Thoratec
- Gambro AB
- Jarvik Heart
Highlights of The Medical Bionic Implants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artificial Heart
- Artificial Kidney
- Artificial Liver
- Artificial Pancreas
- Artificial Lungs
- Others
- By Application:
- Hospitals
- Clinics
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Bionic Implants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical bionic implants are devices that help people with disabilities or injuries regain some level of functionality. They can be used to help people with paralysis, spinal cord injuries, and other conditions.
Some of the major players in the medical bionic implants market are Medtronic, Boston Scientific, Roche, Zimmer Biomet, Asahi Kasei Medical, Baxter International, Abiomed, Berlin Heart, Thoratec, Gambro AB, Jarvik Heart.
The medical bionic implants market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Bionic Implants Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Bionic Implants Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Bionic Implants Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Bionic Implants Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Bionic Implants Market Size & Forecast, 2020-2028
4.5.1 Medical Bionic Implants Market Size and Y-o-Y Growth
4.5.2 Medical Bionic Implants Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Artificial Heart
5.2.2 Artificial Kidney
5.2.3 Artificial Liver
5.2.4 Artificial Pancreas
5.2.5 Artificial Lungs
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Bionic Implants Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Bionic Implants Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Artificial Heart
9.6.2 Artificial Kidney
9.6.3 Artificial Liver
9.6.4 Artificial Pancreas
9.6.5 Artificial Lungs
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Artificial Heart
10.6.2 Artificial Kidney
10.6.3 Artificial Liver
10.6.4 Artificial Pancreas
10.6.5 Artificial Lungs
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Artificial Heart
11.6.2 Artificial Kidney
11.6.3 Artificial Liver
11.6.4 Artificial Pancreas
11.6.5 Artificial Lungs
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Artificial Heart
12.6.2 Artificial Kidney
12.6.3 Artificial Liver
12.6.4 Artificial Pancreas
12.6.5 Artificial Lungs
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Artificial Heart
13.6.2 Artificial Kidney
13.6.3 Artificial Liver
13.6.4 Artificial Pancreas
13.6.5 Artificial Lungs
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Bionic Implants Market: Competitive Dashboard
14.2 Global Medical Bionic Implants Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Boston Scientific
14.3.3 Roche
14.3.4 Zimmer Biomet
14.3.5 Asahi Kasei Medical
14.3.6 Baxter International
14.3.7 Abiomed
14.3.8 Berlin Heart
14.3.9 Thoratec
14.3.10 Gambro AB
14.3.11 Jarvik Heart
